Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first161 to 180 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| IFNB1 interferon beta 1 | 3456 HGNC:5434 | 1 | 471 | 1 | 5 | 14,021 | 36,982 |
| CDKN1A cyclin dependent kinase inhibitor 1A | 1026 HGNC:1784 | 1 | 228 | 0 | 0 | 13,295 | 36,907 |
| CD68 CD68 molecule | 968 HGNC:1693 | 1 | 92 | 0 | 0 | 12,752 | 36,601 |
| MUC1 mucin 1, cell surface associated | 4582 HGNC:7508 | 1 | 194 | 16 | 20 | 6,667 | 36,545 |
| LYZ lysozyme | 4069 HGNC:6740 | 1 | 130 | 0 | 0 | 10,881 | 36,383 |
| SOX2 SRY-box transcription factor 2 | 6657 HGNC:11195 | 1 | 359 | 0 | 0 | 14,106 | 36,341 |
| CASP8 caspase 8 | 841 HGNC:1509 | 1 | 124 | 2 | 14 | 11,078 | 36,248 |
| CCL5 C-C motif chemokine ligand 5 | 6352 HGNC:10632 | 1 | 216 | 0 | 0 | 15,602 | 35,734 |
| TLR2 toll like receptor 2 | 7097 HGNC:11848 | 1 | 123 | 2 | 7 | 13,710 | 35,324 |
| HMOX1 heme oxygenase 1 | 3162 HGNC:5013 | 1 | 101 | 0 | 0 | 8,668 | 35,166 |
| STAT1 signal transducer and activator of transcription 1 | 6772 HGNC:11362 | 1 | 127 | 0 | 0 | 15,715 | 35,016 |
| SIRT1 sirtuin 1 | 23411 HGNC:14929 | 1 | 140 | 2 | 4 | 10,025 | 34,814 |
| HGF hepatocyte growth factor | 3082 HGNC:4893 | 1 | 395 | 2 | 27 | 11,525 | 34,808 |
| ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase | 25 HGNC:76 | 1 | 87 | 36 | 1,467 | 10,675 | 34,797 |
| RHO rhodopsin | 6010 HGNC:10012 | 1 | 113 | 0 | 0 | 16,872 | 34,780 |
| GLP1R glucagon like peptide 1 receptor | 2740 HGNC:4324 | 1 | 65 | 17 | 1,383 | 6,422 | 34,487 |
| ALK ALK receptor tyrosine kinase | 238 HGNC:427 | 1 | 115 | 20 | 339 | 6,157 | 34,371 |
| FOS Fos proto-oncogene, AP-1 transcription factor subunit | 2353 HGNC:3796 | 1 | 118 | 0 | 0 | 17,314 | 34,352 |
| HLA-G major histocompatibility complex, class I, G | 3135 HGNC:4964 | 1 | 275 | 0 | 0 | 10,215 | 34,063 |
| PPARA peroxisome proliferator activated receptor alpha | 5465 HGNC:9232 | 1 | 89 | 27 | 262 | 11,310 | 34,033 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=9
{
"data": {
"total": 193990,
"results": [
{
"id": "3456",
"title": "IFNB1: interferon beta 1",
"summary": "NCBI Gene 3456. 1 protein, 471 patents, 1 drug, 5 trials, 14,021 NIH grants and 36,982 papers.",
"record": "/library/genes/3456",
"gene_id": 3456,
"symbol": "IFNB1",
"name": "interferon beta 1",
"hgnc_id": "HGNC:5434",
"counts": {
"proteins": 1,
"patents": 471,
"drugs": 1,
"trials": 5,
"grants": 14021,
"papers": 36982
}
},
{
"id": "1026",
"title": "CDKN1A: cyclin dependent kinase inhibitor 1A",
"summary": "NCBI Gene 1026. 1 protein, 228 patents, 0 drugs, 0 trials, 13,295 NIH grants and 36,907 papers.",
"record": "/library/genes/1026",
"gene_id": 1026,
"symbol": "CDKN1A",
"name": "cyclin dependent kinase inhibitor 1A",
"hgnc_id": "HGNC:1784",
"counts": {
"proteins": 1,
"patents": 228,
"drugs": 0,
"trials": 0,
"grants": 13295,
"papers": 36907
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=10",
"request_id": "CrFrHdlr_6w2rKk5"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant